quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:12:54·1711d
SECFiling
Ibere Pharmaceuticals logo

SEC Form 8-K/A filed by Ibere Pharmaceuticals (Amendment)

IBER· Ibere Pharmaceuticals
Finance
Full content unavailable. See the original source below.
Original source

Companies

  • IBER
    Ibere Pharmaceuticals
    Finance

Related

  • SEC1137d
    SEC Form 15-12G filed by Ibere Pharmaceuticals
  • SEC1148d
    SEC Form 25-NSE filed by Ibere Pharmaceuticals
  • SEC1163d
    Ibere Pharmaceuticals filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • NEWS1163d
    Ibere Pharmaceuticals Will Redeem All Outstanding Ordinary Shares Included In Units Issued In IPO Effective As Of Close Of Business On March 2; Per-Share Redemption Price For Public Shares Will Be ~$10.17; Expects That NYSE Will File Form 25 To Delist Co
  • 13D/G1164d
    SEC Form SC 13G filed by Ibere Pharmaceuticals
  • 13D/G1164d
    SEC Form SC 13G/A filed by Ibere Pharmaceuticals (Amendment)
  • 13D/G1170d
    SEC Form SC 13G filed by Ibere Pharmaceuticals
  • 13D/G1170d
    SEC Form SC 13G/A filed by Ibere Pharmaceuticals (Amendment)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022